# Teriparatide on Maxillary Sinus Floor Osseointegration

> **NCT06061354** · PHASE4 · UNKNOWN · sponsor: **Universidad de Valparaiso** · enrollment: 42 (estimated)

## Conditions studied

- Bone Regeneration

## Interventions

- **DRUG:** Teriparatide
- **PROCEDURE:** Maxillary Sinus Augmentation
- **PROCEDURE:** Dental Implant Installation
- **COMBINATION_PRODUCT:** Bone graft

## Key facts

- **NCT ID:** NCT06061354
- **Lead sponsor:** Universidad de Valparaiso
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-23
- **Primary completion:** 2024-08
- **Final completion:** 2024-12
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2023-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06061354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06061354, "Teriparatide on Maxillary Sinus Floor Osseointegration". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06061354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*